Clinical Study Reports

  • Search by category

  • Show all

Clinical Study Reports

November 23, 2024
 - Tim Hardman
[wpdreams_ajaxsearchlite]

About the author

Tim Hardman

Managing Director
View profile
Dr Tim Hardman is Managing Director of Niche Science & Technology Ltd., a bespoke services CRO based in the UK. He is also Chairman of the Association of Human Pharmacology in the Pharmaceutical Industry, the representative industry body for early for early phase clinical studies in the UK, and President of the sister organisation the European Federation for Exploratory Medicines Development. Dr Hardman is a keen scientist and an occasional commentator on all aspects of medicine, business and the process of drug development.

Clinical Study Reports

This resource from the Niche medical writing team provides a guide for efficiently creating well-informed clinical consensus statements, which address clinical challenges with limited evidence.

It outlines a structured approach involving expert identification, project planning, team recruitment, and active facilitation to reach agreed opinions. The document emphasizes the importance of clearly defining the scope, employing methods like Delphi surveys, and managing the consensus process through meetings and defined roles.

It distinguishes consensus statements from clinical practice guidelines, highlighting their role in reducing uncertainty and improving care quality where evidence is lacking.

Furthermore, the text underscores the need for effective dissemination beyond publication and the importance of considering future updates to maintain relevance.

November 23, 2024
 - Tim Hardman

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility